LSU Pennington Biomedical Research taking part in pediatric Moderna vaccine trial

BATON ROUGE, La. (WAFB) — Pfizer recently announced that their COVID-19 vaccine is working for children ages 5 to 11, but another company is taking its own steps.

LSU Pennington Biomedical Research Center is conducting a vaccination trial to determine the safety and effectiveness of the Moderna vaccine in children.

The trial involves 4,000 children across the country, with 35 coming from the metropolitan area. dr. Daniel Hsia said most children received their first dose in August and their second dose in September.

He added that 75% will receive the vaccine and 25% the placebo.

“Trying to get a vaccine approved in this age group is very important to really take the next step in ending the pandemic,” said Dr. hsia.

Ginger Brininstool has signed her 9-year-old daughter, Megan Pollock, to participate in the trial. She said that after seeing the effect of the delta variant on children, she didn’t think twice.

“When she got the chance this summer, it was an easy choice. There was no hesitation,” Brininstool said.

dr. Hsia went into detail about the importance of the trial.

“We want to make sure this is safe, and we want to make sure that if there are any adverse side effects, they’re reported and they’re very well documented, and we’re comparing them to what we’ve seen before in adults,” he said. hsia.

Hsia said each child was given a smaller dose compared to what an adult would get, and the side effects he’s seen are almost the same.

Fever and a sore arm, all the same things Pollock said she had after her second shot.

“I wasn’t that excited because all the shots hurt me, but when I got it, it didn’t hurt that bad,” Pollock said.

Brininstool understands that there are parents who wouldn’t have done what she did, but she believes the reward outweighs the risk.

“If I can do something small to prevent my child from getting a deadly disease, I’m all for it,” Brininstool said.

The process is a one-year process, but this family is ready.

“I’d love to stay for another 50 years, and honestly I wish she’d be around even longer,” Brininstool said.

“Not only are we helping the community on the ground, but these are groundbreaking studies we are doing that could impact the lives of millions of people worldwide,” Hsia says.

dr. Hsia said the first part of this trial only included children between the ages of 6 and 11. They will start the second part in October with children between the ages of 6 and 6 months.

You can contact the Center at 225-763-3000 for more information.

Click here to report a typo.

Copyright 2021 WAFB. All rights reserved.

Comments are closed.